Hua Peng

5.2k total citations · 2 hit papers
67 papers, 3.4k citations indexed

About

Hua Peng is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Hua Peng has authored 67 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 20 papers in Molecular Biology and 17 papers in Epidemiology. Recurrent topics in Hua Peng's work include Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (13 papers) and CAR-T cell therapy research (9 papers). Hua Peng is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (13 papers) and CAR-T cell therapy research (9 papers). Hua Peng collaborates with scholars based in China, United States and Czechia. Hua Peng's co-authors include Yang‐Xin Fu, Hairong Xu, Jingya Guo, Yong Liang, Justin Kline, William A. Frazier, Xiaojuan Liu, Kyle R. Cron, Yang Pu and Meng Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Hua Peng

64 papers receiving 3.3k citations

Hit Papers

CD47 blockade triggers T cell–mediated destruction of imm... 2015 2026 2018 2022 2015 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Peng China 28 1.7k 1.1k 1.0k 620 324 67 3.4k
Réjean Lapointe Canada 30 2.1k 1.2× 1.0k 0.9× 1.2k 1.2× 372 0.6× 221 0.7× 80 4.0k
Alexei V. Tumanov United States 34 2.5k 1.5× 1.1k 1.0× 554 0.5× 363 0.6× 381 1.2× 91 4.1k
Hitoshi Hasegawa Japan 42 2.3k 1.4× 1.1k 1.0× 1.0k 1.0× 419 0.7× 187 0.6× 190 5.1k
Sven Burgdorf Germany 25 2.3k 1.3× 1.3k 1.2× 390 0.4× 321 0.5× 193 0.6× 42 3.6k
Agustı́n Valenzuela-Fernández Spain 26 704 0.4× 1.2k 1.1× 680 0.7× 413 0.7× 128 0.4× 51 2.7k
Edith M. Hessel United Kingdom 32 2.4k 1.4× 925 0.8× 442 0.4× 586 0.9× 193 0.6× 73 4.6k
Lei Jin China 39 3.4k 2.0× 1.7k 1.6× 894 0.9× 889 1.4× 485 1.5× 121 5.3k
Marı́a Rosa Bono Chile 31 1.9k 1.1× 1.2k 1.1× 469 0.5× 355 0.6× 157 0.5× 98 3.9k
Alison Simmons United Kingdom 28 1.7k 1.0× 1.7k 1.6× 594 0.6× 780 1.3× 286 0.9× 69 4.0k
Stephen B. Willingham United States 23 3.1k 1.8× 2.5k 2.3× 1.1k 1.0× 400 0.6× 208 0.6× 43 5.5k

Countries citing papers authored by Hua Peng

Since Specialization
Citations

This map shows the geographic impact of Hua Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Peng more than expected).

Fields of papers citing papers by Hua Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Peng. The network helps show where Hua Peng may publish in the future.

Co-authorship network of co-authors of Hua Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Peng. A scholar is included among the top collaborators of Hua Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Peng. Hua Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xuemei, Yan Guo, Xuan Li, et al.. (2025). Astaxanthin Prevented Acute Alcoholic Cardiomyopathy by Maintenance of Mitophagy‐Mediated Mitochondrial Homeostasis. Journal of Cellular and Molecular Medicine. 29(13). e70714–e70714. 3 indexed citations
2.
Liao, Xuejiao, Zhaoyong Zhang, Xiuye Wang, et al.. (2025). Sequential intranasal booster triggers class switching from intramuscularly primed IgG to mucosal IgA against SARS-CoV-2. Journal of Clinical Investigation. 135(5). 2 indexed citations
6.
Guo, Jingya, et al.. (2022). An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery. The Journal of Experimental Medicine. 219(12). 29 indexed citations
7.
Han, Chuanhui, Victoria Godfrey, Zhida Liu, et al.. (2021). The AIM2 and NLRP3 inflammasomes trigger IL-1–mediated antitumor effects during radiation. Science Immunology. 6(59). 66 indexed citations
8.
Zhou, Yihua, Chao Wu, Yuan Feng, et al.. (2021). LIGHT of pulmonary NKT cells annihilates tissue protective alveolar macrophages in augmenting severe influenza pneumonia. Science Bulletin. 66(20). 2124–2134. 4 indexed citations
9.
Qi, Peng, Xiangyan Qiu, Zihan Zhang, et al.. (2020). PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade. Nature Communications. 11(1). 4835–4835. 370 indexed citations breakdown →
10.
Wang, Wenjun, Xiaoxiao Zhou, Yingjie Bian, et al.. (2020). Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nature Nanotechnology. 15(5). 406–416. 182 indexed citations
11.
Sun, Zhichen, Zhenhua Ren, Kaiting Yang, et al.. (2019). A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control. Nature Communications. 10(1). 3874–3874. 147 indexed citations
12.
Yang, Kaiting, Yong Liang, Zhichen Sun, et al.. (2018). T cell-derived lymphotoxin limits Th1 response during HSV-1 infection. Scientific Reports. 8(1). 17727–17727. 5 indexed citations
13.
Liang, Yong, Haidong Tang, Jingya Guo, et al.. (2018). Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance. Nature Communications. 9(1). 4586–4586. 69 indexed citations
14.
Liao, Jing, Yan Luan, Zhenhua Ren, et al.. (2017). Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression. Cancer Immunology Research. 5(7). 560–570. 13 indexed citations
15.
Ren, Zhenhua, Jingya Guo, Jing Liao, et al.. (2016). CTLA-4 Limits Anti-CD20–Mediated Tumor Regression. Clinical Cancer Research. 23(1). 193–203. 34 indexed citations
16.
Zhang, Lin, Yixin Xu, Jianhua Zhuang, et al.. (2016). Effect of low-intensity pure tone auditory stimulation on patients with rapid eye movement sleep behavior disorder. Neurological Research. 38(9). 792–798. 1 indexed citations
17.
Liang, Yong, et al.. (2015). Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication. Scientific Reports. 5(1). 10406–10406. 8 indexed citations
18.
Yang, Dan, Longchao Liu, Hua Peng, et al.. (2013). A mouse model for HBV immunotolerance and immunotherapy. Cellular and Molecular Immunology. 11(1). 71–78. 105 indexed citations
19.
Xu, Jin, et al.. (2011). Orthezia quadrua (Homoptera: Ortheziidae): a native natural enemy of Ageratina adenophora and Chromolaena odorata.. Yunnan Nongye Daxue xuebao. 26(4). 577–579. 6 indexed citations
20.
Peng, Hua. (2009). Trichosanthin inhibited the proliferation of MDA-MB-231 cells and reversed the methylation of syk gene. Tumori. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026